Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
62 hedge funds and large institutions have $757M invested in Enfusion, Inc. in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 14 closing their positions.
145% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
3% less funds holding
Funds holding: 64 → 62 (-2)
19% less capital invested
Capital invested by funds: $931M → $757M (-$173M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$26.4M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$3.58M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
+$3.42M |
| 4 |
ACM
Ararat Capital Management
Westport,
Connecticut
|
+$3.34M |
| 5 |
BlackRock
New York
|
+$2.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$6.67M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$6.58M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$5M |
| 4 |
1WCM
12 West Capital Management
New York
|
-$3.82M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.58M |
ENFN Hedge Fund Activity: Q2 2022 in Review
62 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q2 2022, worth a combined $757M — down 19% from $931M a quarter earlier.
Fund positioning in ENFN was balanced in Q2 2022: 14 funds opened new positions, 14 closed out, 27 added to existing stakes and 11 trimmed.
The largest buyer was Brown Capital Management, opening a new position worth an estimated $26.4M. The largest seller was BAMCO Inc, exiting entirely with an estimated $6.67M sold.
- 62 institutional investors held Enfusion, Inc. (ENFN) as of Q2 2022, down from 64 in Q1 2022.
- Funds reported $757M of Enfusion, Inc. stock for Q2 2022, down 19% quarter-over-quarter.
- 14 funds opened new Enfusion, Inc. positions in Q2 2022 and 14 closed out, a net change of 0 holders.
- The largest Enfusion, Inc. buyer in Q2 2022 was Brown Capital Management, an estimated $26.4M added.
- The largest Enfusion, Inc. seller in Q2 2022 was BAMCO Inc, an estimated $6.67M sold.
Based on aggregated 13F filings for Q2 2022.